Skip to main content

  • Prevalence of high on-treatment (aspirin and clopidogrel) platelet reactivity in patients with critical limb ischemia

    • Posted: 08/02/2018
    • Author:

       

      Leonardo C. Clavijo, Noor Al-Asady, Ashwat Dhillon, Ray V. Matthews, ... David M. Shavelle

       

    • 2018CRM

    Abstract

    Objectives

    The goal of this study is to establish the prevalence of high on-treatment platelet reactivity to aspirin (HPRA) and clopidogrel (HPRC) in patients with critical limb ischemia (CLI).

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details